Microbix Biosystems Inc.
Microbix Biosystems Inc. (MBX.TO) Revenue
Annual & quarterly revenue history · segment & region breakdown
MBX.TO · revenue · updated Jun 9, 2026
Core revenue metrics
Trailing 12 monthsMicrobix Biosystems Inc. trailing twelve-month (TTM) revenue is $0.01B, a decrease of 26.81% year-over-year from $0.02B in FY2025.
Revenue trend
2025 – 2006 · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|---|---|---|
| 2025-09-30 | $0.02B | -$0.01B | -26.81% |
| 2024-09-30 | $0.03B | +$0.01B | +53.77% |
| 2023-09-30 | $0.02B | -$0.00B | -13.43% |
| 2022-09-30 | $0.02B | +$0.00B | +2.60% |
| 2021-09-30 | $0.02B | +$0.01B | +76.66% |
| 2020-09-30 | $0.01B | -$0.00B | -21.53% |
| 2019-09-30 | $0.01B | +$0.00B | +7.21% |
| 2018-09-30 | $0.01B | +$0.00B | +22.82% |
| 2017-09-30 | $0.01B | +$0.00B | +7.03% |
| 2016-09-30 | $0.01B | +$0.00B | +7.25% |
About Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income Microbix Biosystems Inc. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
Microbix Biosystems Inc. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in CAD.
Data sourced from Microbix Biosystems Inc.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
MBX.TO revenue · 4 questionsMBX.TO's trailing twelve-month (TTM) revenue is $0.01B. That is a decrease of 26.81% year-over-year from $0.02B in FY2025.
▸ Source: FMP · Microbix Biosystems Inc. SEC filings · GAAP · Microbix Biosystems Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026